There is a large volume of literature published on the management of stable thoracolumbar burst fractures; however the ideal management of these common injuries remains debated. A variety of treatment options exist of which none have been shown to be superior. The default treatment was historically bed rest for several weeks followed by ambulant orthotic support. This has become less popular in recent times as prolonged recumbence has fallen from favour. Increasing cost burden, poor patient tolerance and clinician preference have resulted in earlier mobilisation with orthotics and earlier weaning out of the brace.
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Our understanding of spinal stability in thoracolumbar fractures has evolved and the stable type fracture patterns are well described, giving confidence in earlier patient mobilisation. It is now known that there is no correlation between the duration of bed rest and degree of kyphotic progression after mobilisation during conservative treatment.
Some authors have questioned whether bracing is even required with stable fractures. Indeed, a retrospective study of 38 patients with 4-year follow-up in 1999 did not demonstrate any difference in outcome between bracing and no brace in stable thoracolumbar fractures.
This study specifically looked at clinical equivalence between orthosis and no orthosis and is of great interest, especially as many clinicians have questioned the efficacy of bracing at all.
This was a multicentre prospective randomised clinical equivalence trial in which the authors compared outcomes in thoracolumbar burst fractures treated with and without a thoracolumbosacral orthosis.
Patient inclusion criteria were AO Classification Type A3 burst fractures between T-11 and L-3, skeletal maturity up to age 60 years, admission within 72 hours of injury, initial kyphotic deformity <35°, and no neurological deficits.
The primary outcome measure was based on the RolandMorris Disability Questionnaire assessed at 3 months post injury. Secondary outcomes included pain, functional outcome, health-related quality of life, sagittal alignment, length of hospital stay, and complications.
Patients with no brace were ambulated immediately following randomisation, maintaining 'neutral spinal alignment' for 8 weeks. Patients in the TLSO group were given bed rest until a brace was fitted, mobilised and weaned from the brace at 8 weeks over a 2-week period.
Sixty-nine patients were followed to 3 months and 47 were followed for up to 1 year. No significant difference was found between treatment groups for any outcome measure at any stage in the follow-up period. There were four failures requiring surgical intervention, three in the TLSO group and one in the non-TLSO group.
The authors concluded that there was equivalence between treatment with a TLSO and no orthosis for thoracolumbar AO Type A3 burst fractures.
The authors acknowledge that since the interim analysis was performed at the 50% recruitment mark, the sample size was relatively small and underpowered.
However this excellent, well-structured study does suggest that where there is an absence of posterior column injury in a thoracolumbar burst fracture, this injury is stable and abstaining from brace treatment is safe and equivalent to bracing. T his article aims to elucidate the indications for use of interspinous spacers through an analysis of the better quality literature available on the matter. An attempt is made to quantify effectiveness and highlight potential complications. The main objective is to evaluate whether surgeries with interspinous spacers demonstrate superior outcomes to bony decompression, or at least conservative treatment for intermittent neurogenic claudication secondary to lumbar spinal stenosis.
The authors performed a search of MEDLINE, EMBASE, Web of Science, Cochrane, CINAHL, Academic Search Premier and Science direct for available subject matter as published up to 1 July 2010. Reporting based on validated outcome scores (ZCQ -Zurich Claudication Questionnaire, Modified Roland Disability Questionnaire for Sciatica, Oswestry Disability Index, VASVisual Analogue Scale leg-and back pain), speaks to sound scientific principles, and was a prerequisite for inclusion.
The literature was categorised as: systematic reviews (validated through steps as outlined by Furlan and Van Tulder); randomised controlled trials (assessed for methodology quality through the Cochrane quality measurements adapted by Furlan and Van Tulder -high quality defined as 50% or more); and prospective cohort studies of high quality (methodological quality measured on the Dutch Cochrane Centre Quality Assessment scale -score < 6 defined as low quality). The authors ensure quality of the included material through this. Following quality assessment, only three randomised controlled trials and eight prospective cohorts were included from the initial 253 references. No systematic reviews could be found. This is unfortunate as it dramatically reduces the gravity of recommendations; this is however the best that is available to the scientific community.
Three reports described two randomised clinical trials (RCTs), with two of these studies describing the same patient sample after one-and two-year follow-up, respectively (Zucherman) (both with methodological scores of 5 -low quality). The other RCT included was of high quality with a score of 6 (Furlan and Van Tulder criteria) (Anderson et al). These reports all compared interspinous spacers to non-operative management.
Only one of the eight cohort studies had a methodological quality score of 6 (high quality); the rest were all considered to be of low quality with high risk for bias. One of the observational cohorts described two surgical cohorts with interspinous spacers following decompression versus decompression alone (Richter et al This paper provides the interesting addition of biomechanical evidence, and was not included in the abovementioned article's data, as the date of publication (December 2010) fell outside the search parameters. A total of 563 patients were treated with interspinous spacers in the mentioned studies. All studies showed improvement in validated outcome scores at six weeks and at one year. Pooled data from the RCTs supports the use of interspinous spacers over conservative management. Interestingly the cohort description of patients with surgical decompression aided by interspinous spacers compared to the cohort with surgical decompression alone (no interspinous spacer) showed no statistical difference between the groups, with improved short-and long-term outcome scores in both cohorts (Richter et al) .
The overall interspinous spacer complication rate of 7% includes 6% device failure (n=31) requiring re-operation. This figure is fairly high, and might be under-reported in the relatively short follow-up period (one year). Six other complications were reported (1%) and included infection and 'post-operative leakages'.
This article concludes that the available body of literature shows decompression through interspinous spacers to be superior to conservative (non-surgical treatment) for patients with intermittent neurogenic claudication secondary to degenerative spinal stenosis. The level of evidence however is debatable, and the term of follow-up was limited.
There is no literature available comparing outcome in patients with interspinous spacers to surgical decompression alone.
Complication rates overall (7%) are comparable to surgical decompression but implant failures constitute 6% of the 7% reported complications. This is unacceptably high in my opinion.
Despite the meagre evidence available, interspinous spacers have seen a meteoric rise in use, often for various and unconfirmed indications. A large section of the available body of literature is industry-driven.
This article highlights the lack of quality evidence in the use of and indications for interspinous spacers, as well as the longterm outcomes. The authors reviewed 159 patients treated by a variety of operations by a single surgeon in a prospective 2-year study. Possible operations were posterior spinal fusion (PSF), anterior spinal fusion (ASF), video-assisted thoracoscopic release and instrumentation (VATS-I) or video-assisted thoracoscopic release and PSF (VATS-PSF).
The largest group was the 90 patients with main thoracic curves (Lenke 1), none of whom had ASF. The 22 patients treated by VATS-PSF had significantly larger curves, and all ASF patients had thoraco-lumbar or lumbar curves (Lenke 5). Taken together, these make correlation of respiratory function and surgical approach problematic but some reasonable conclusions may be drawn.
In Lenke 1 patients, PSF and VATS-I produced similar curve correction and improvement in SRS-22 scores.
In both VATS groups, respiratory functions were significantly reduced in the post-operative period, but resolved by 6 months except for FEV1, which remained slightly reduced at 2 years.
Recovery of pulmonary function was better after VATS-PSF than PSF or VATS-I.
The authors concluded that VATS procedures for thoracic curves, and open anterior approaches for thoraco-lumbar or lumbar curves, caused minimal to no permanent respiratory deficits compared to posterior surgery.
Despite the flaws in the study, and the absence of clear guidelines to the surgeon on which approach to use, this article shows that thoracoscopic surgery does have short-term but reversible effects on respiration, and can be useful in thoracic deformities. It also shows that anterior surgery is quite acceptable for Lenke 5 curves. The unresolved problem is whether anterior surgery is justified in main thoracic (Lenke 1) curves. S coliosis correction surgery, like any operation, involves balancing the benefits against risks. A longer fusion may assure better correction but at the possible cost of unnecessary loss of mobility or function, and the increased risk of degeneration below the fusion. Too short a fusion may result in residual or recurrent deformity potentially requiring additional surgery -the so-called add-on effect. Selection of the distal fusion level is therefore critical to achieve the best compromise. Traditional guidelines such as fusing to two levels below the end vertebra (EV) (Harrington), the stable vertebra (SV) bisected by the central sacro-vertebral line (CSV)(King), or to the neutral vertebra (Moe), were developed before the modern powerful instrumentation systems were available, and are now of doubtful value.
To find the risk factors for adding on, and to determine the best lowest instrumented vertebra (LIV) in single thoracic (Lenke 1A) scoliosis, the authors reviewed 45 patients treated by posterior segmental pedicle screw/rod constructs. Adding on was defined as progressive increase of the primary curve, with either an increase of 5 mm deviation from the CSVL, or more than 5° wedging of the disc below the lowest instrumented vertebra (LIV) at 1-year follow-up.
Of the 45 patients, 23 met the criteria for adding on. Risk factors identified were age; difference between SV or EV and LIV; and deviation of the vertebra below the planned lowest instrumented vertebra (LIV+1) from the CSVL. Analysis by a multiple logistic model showed that the single independent predictive factor for progression was an LIV+1 deviation of more than 10 mm from the CSVL (p=0.008).
The authors recommend that in Lenke 1A curves, the fusion should extend down to the most cephalad vertebra deviating 10 mm from the central sacro-vertebral line. Distal adding-on phenomenon in Lenke 1A scoliosis Yu Wang, Cody Eric Bünger, Ebbe Stender Hansen, et al. Spine 2011; 36(14):1113-22 Concept: Are we protecting articular cartilage for long enough after surgery?
Reviewer
The natural history of the chondral pathology which results in post-traumatic osteoarthritis, following a closed joint injury, is not well understood or described. Any arthroscopic surgical event is in fact also a traumatic joint injury event and may play a role in post-traumatic osteoarthritis in the long term.
The first article by Young et al, gives a significant insight into the inflammatory response generated in articular cartilage following a closed joint injury. This study used delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC). This provides an in vivo method for the assessment of the biochemical composition of articular cartilage and provides a surrogate measure of glycosaminoglycan content.
The study demonstrates that closed joint injury without bone bruising, articular or meniscal cartilage injury still produced a significant decrease in articular cartilage glycosaminoglycan content for a period of three to six months. Glycosaminoglycan loss from articular cartilage has been proven to have a significant impact on its biomechanical properties. The result is softer cartilage, making it susceptible to further chondral injury or accelerated wear during the recovery phase.
Every arthroscopic surgery produces a local inflammatory response within the associated joint. It follows that every arthroscopic surgery produces articular cartilage softening as a result of the natural inflammatory response. It will then take six months for the cartilage to return to its pre-injury status.
The second article, by Kocoaglu et al, looked at the effect of arthroscopic irrigation solution temperature on articular cartilage chondrocyte metabolism.
Porcine cartilage explants were immersed either at 4 °C, at room temperature (24 °C), at normal knee temperature (32 °C) or at near-core body temperature (37 °C) All specimens were immersed for 2 hours. Lactate and proteoglycan production and RNA yield analyses were used to assess cartilage metabolism at different temperatures. Glycosaminoglycan content was measured.
The study showed that the short-term exposure to cold fluids, including room temperature, had detrimental effects on chondrocyte function. There was a statistically significant suppression of metabolism and a decrease in glycosaminoglycan content.
This study augments the results of the previous study to suggest that any inflammatory response of the articular cartilage reduces glycosaminoglycan content which results in articular cartilage softening.
These studies demonstrate the sensitivity of articular cartilage to insult, and the decrease in glycosaminoglycan content which results.
Hence: 1. Arthroscopic lavage fluid should be warmed to around 32°C. 2. After any joint injury which results in an effusion or any arthroscopic intervention it would be significantly beneficial to protect the involved joint for an extended period. To what extent we need to protect the joint, whether it be bracing, immobilisation or decreased weight-bearing, is unclear. However these studies do seem to indicate that we should be limiting all impact sporting activities of the affected joint for a period of three to six months.
